NEW YORK, NEW YORK - JULY 23: Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024, in New York City. In the U.S. drug market, higher list prices can paradoxically ...
The pharmaceuticals lobby shored up its campaign against increasing use of the 340B Drug Discount Program with a new analysis estimating its broader use pulled $6.5 billion in rebates away from the ...
The rapid expansion of the federal 340B drug pricing program is significantly affecting Medicaid budgets, particularly in states where managed care plans oversee prescription drug benefits. New ...
The Medicare Innovation Center has proposed two drug pricing models that would lower the cost of certain drugs to reflect international prices, which are often significantly lower than what U.S.
Cigna Group’s decision to eliminate prescription drug rebates from many of its health plans marks one of the biggest shifts in the US pharmaceutical supply chain in decades. The change, set to begin ...
On July 31, 2025, the U.S. Department of Health and Human Services (HHS) announced that it will conduct a pilot program testing out a rebate model for 340B drug purchases. Under the program, drug ...
The Center for Medicare and Medicaid Innovation (CMMI)[1] recently released information about three new models aimed at testing alternative calculations for manufacturer rebates, to ensure net drug ...
The Health Resources and Services Administration Feb. 25 said it will extend the deadline to April 20 to receive comments on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results